Page 7 - 8 PAGES thyroid
P. 7
AFTERNOON SESSION 14:00-14:30 Management of Recurrent/Persistent Disease in Patients with Papillary Thyroid Cancer: Pro/Contra Recurrent Radioiodine Treatment Michal Weiler-Sagie, MD, PhD (Nuclear Medicine) Jamal Zidan, MD (Oncology) 14:30-15:20 The Use of Tyrosine Kinase Inhibitors in Patients with Papillary Thyroid Cancer Ezra Cohen, MD (Oncology) 15:20-16:00 Who Should be Treated with Tyrosine Kinase Inhibitors: Case Discussions Salem Billan, MD (Oncology) Aron Popovzer, MD (Oncology) 16:00-16:20 Panel Discussion: The Use of Tyrosine Kinase Inhibitors in Patients with Papillary Thyroid Cancer Moderator: Ziv Gil, MD, PhD (ENT) Carlos Benbassat, MD (Endocrinology) Salem Billan, MD (Oncology) Ezra Cohen, MD (Oncology) Aron Popovzer, MD (Oncology) R Michael Tuttle, MD (Endocrinology) 16:20 Closing Remarks
